CAB39L
Basic information
Region (hg38): 13:49308650-49444064
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAB39L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 1 | 0 |
Variants in CAB39L
This is a list of pathogenic ClinVar variants found in the CAB39L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-49310824-G-A | not specified | Uncertain significance (Sep 26, 2024) | ||
13-49310834-A-C | not specified | Uncertain significance (Dec 19, 2023) | ||
13-49310857-T-C | not specified | Uncertain significance (Oct 14, 2023) | ||
13-49310873-C-T | not specified | Likely benign (Aug 13, 2021) | ||
13-49310901-T-G | not specified | Uncertain significance (May 15, 2024) | ||
13-49310923-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
13-49310957-C-T | not specified | Uncertain significance (Jun 10, 2024) | ||
13-49332009-T-A | not specified | Uncertain significance (Sep 28, 2022) | ||
13-49332042-T-C | not specified | Uncertain significance (Dec 09, 2023) | ||
13-49332051-T-C | not specified | Uncertain significance (Jun 17, 2022) | ||
13-49332072-G-C | not specified | Uncertain significance (Dec 10, 2024) | ||
13-49339697-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
13-49350856-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
13-49350886-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
13-49350912-T-C | not specified | Likely benign (Jul 25, 2024) | ||
13-49359745-G-C | not specified | Uncertain significance (Jun 07, 2023) | ||
13-49359754-T-C | not specified | Uncertain significance (Dec 30, 2023) | ||
13-49359771-C-A | not specified | Uncertain significance (Oct 29, 2024) | ||
13-49359778-T-C | not specified | Uncertain significance (Aug 15, 2024) | ||
13-49376983-T-C | not specified | Uncertain significance (Jun 27, 2022) | ||
13-49376990-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
13-49377005-C-A | not specified | Uncertain significance (Nov 27, 2024) | ||
13-49377010-A-C | not specified | Uncertain significance (Oct 26, 2021) | ||
13-49377011-G-C | not specified | Uncertain significance (Oct 26, 2021) | ||
13-49377058-G-A | not specified | Uncertain significance (Nov 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAB39L | protein_coding | protein_coding | ENST00000355854 | 8 | 135477 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000639 | 0.909 | 125620 | 0 | 128 | 125748 | 0.000509 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.638 | 150 | 174 | 0.864 | 0.00000881 | 2238 |
Missense in Polyphen | 53 | 65.683 | 0.8069 | 884 | ||
Synonymous | 0.549 | 59 | 64.6 | 0.913 | 0.00000350 | 599 |
Loss of Function | 1.56 | 9 | 15.7 | 0.575 | 7.23e-7 | 213 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00224 | 0.00224 |
Ashkenazi Jewish | 0.000106 | 0.0000992 |
East Asian | 0.000889 | 0.000870 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000267 | 0.000264 |
Middle Eastern | 0.000889 | 0.000870 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1 (By similarity). {ECO:0000250}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Signal Transduction;Energy dependent regulation of mTOR by LKB1-AMPK;mTOR signalling
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.915
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 17.03
Haploinsufficiency Scores
- pHI
- 0.428
- hipred
- Y
- hipred_score
- 0.713
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.871
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cab39l
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- cell cycle arrest;signal transduction by protein phosphorylation
- Cellular component
- cytosol
- Molecular function
- protein serine/threonine kinase activity;protein binding